S&P 500   5,115.27 (+0.37%)
DOW   38,996.43 (+0.00%)
QQQ   443.24 (+0.97%)
AAPL   178.41 (-1.29%)
MSFT   413.02 (-0.15%)
META   500.24 (+2.06%)
GOOGL   137.68 (-0.56%)
AMZN   177.97 (+0.68%)
TSLA   200.66 (-0.60%)
NVDA   817.28 (+3.31%)
NIO   5.81 (+1.04%)
AMD   198.68 (+3.19%)
BABA   74.81 (+1.05%)
T   16.96 (+0.18%)
F   12.52 (+0.64%)
MU   95.86 (+5.79%)
CGC   3.28 (-0.30%)
GE   158.68 (+1.14%)
DIS   111.57 (+-0.01%)
AMC   4.45 (+3.01%)
PFE   26.62 (+0.23%)
PYPL   61.03 (+1.14%)
XOM   106.29 (+1.69%)
S&P 500   5,115.27 (+0.37%)
DOW   38,996.43 (+0.00%)
QQQ   443.24 (+0.97%)
AAPL   178.41 (-1.29%)
MSFT   413.02 (-0.15%)
META   500.24 (+2.06%)
GOOGL   137.68 (-0.56%)
AMZN   177.97 (+0.68%)
TSLA   200.66 (-0.60%)
NVDA   817.28 (+3.31%)
NIO   5.81 (+1.04%)
AMD   198.68 (+3.19%)
BABA   74.81 (+1.05%)
T   16.96 (+0.18%)
F   12.52 (+0.64%)
MU   95.86 (+5.79%)
CGC   3.28 (-0.30%)
GE   158.68 (+1.14%)
DIS   111.57 (+-0.01%)
AMC   4.45 (+3.01%)
PFE   26.62 (+0.23%)
PYPL   61.03 (+1.14%)
XOM   106.29 (+1.69%)
S&P 500   5,115.27 (+0.37%)
DOW   38,996.43 (+0.00%)
QQQ   443.24 (+0.97%)
AAPL   178.41 (-1.29%)
MSFT   413.02 (-0.15%)
META   500.24 (+2.06%)
GOOGL   137.68 (-0.56%)
AMZN   177.97 (+0.68%)
TSLA   200.66 (-0.60%)
NVDA   817.28 (+3.31%)
NIO   5.81 (+1.04%)
AMD   198.68 (+3.19%)
BABA   74.81 (+1.05%)
T   16.96 (+0.18%)
F   12.52 (+0.64%)
MU   95.86 (+5.79%)
CGC   3.28 (-0.30%)
GE   158.68 (+1.14%)
DIS   111.57 (+-0.01%)
AMC   4.45 (+3.01%)
PFE   26.62 (+0.23%)
PYPL   61.03 (+1.14%)
XOM   106.29 (+1.69%)
S&P 500   5,115.27 (+0.37%)
DOW   38,996.43 (+0.00%)
QQQ   443.24 (+0.97%)
AAPL   178.41 (-1.29%)
MSFT   413.02 (-0.15%)
META   500.24 (+2.06%)
GOOGL   137.68 (-0.56%)
AMZN   177.97 (+0.68%)
TSLA   200.66 (-0.60%)
NVDA   817.28 (+3.31%)
NIO   5.81 (+1.04%)
AMD   198.68 (+3.19%)
BABA   74.81 (+1.05%)
T   16.96 (+0.18%)
F   12.52 (+0.64%)
MU   95.86 (+5.79%)
CGC   3.28 (-0.30%)
GE   158.68 (+1.14%)
DIS   111.57 (+-0.01%)
AMC   4.45 (+3.01%)
PFE   26.62 (+0.23%)
PYPL   61.03 (+1.14%)
XOM   106.29 (+1.69%)

Phreesia (PHR) Stock Price, News & Analysis

$25.29
+0.54 (+2.18%)
(As of 11:20 AM ET)
Today's Range
$24.46
$25.47
50-Day Range
$22.04
$28.87
52-Week Range
$12.05
$38.86
Volume
63,767 shs
Average Volume
508,984 shs
Market Capitalization
$1.41 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$33.79

Phreesia MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.93 Rating Score
Upside/​Downside
36.5% Upside
$33.79 Price Target
Short Interest
Healthy
4.12% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.60
Upright™ Environmental Score
News Sentiment
0.56mentions of Phreesia in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$251,630 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.35) to ($1.47) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.71 out of 5 stars

Medical Sector

76th out of 957 stocks

Business Services, Not Elsewhere Classified Industry

8th out of 89 stocks


PHR stock logo

About Phreesia Stock (NYSE:PHR)

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Wilmington, Delaware.

PHR Stock Price History

PHR Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Truist Financial Begins Coverage on Phreesia (NYSE:PHR)
Assessing Phreesia: Insights From 7 Financial Analysts
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Phreesia Stock (NYSE:PHR), Short Interest Report
Phreesia (PHR) Rose on 2024 Guidance
CCL Mar 2024 12.000 put
CCL Feb 2024 20.500 put
Bull Of The Day: Phreesia (PHR)
New Strong Buy Stocks for January 29th
Phreesia Inc CFO Balaji Gandhi Sells 10,124 Shares
5 Analysts Have This To Say About Phreesia
Phreesia (PHR) Earnings Dates & Reports
What Caused a -40% Drop in Phreesia (PHR) Shares?
See More Headlines
Receive PHR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phreesia and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/06/2023
Today
3/01/2024
Next Earnings (Confirmed)
3/14/2024
Fiscal Year End
1/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Employees
1,546
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$33.79
High Stock Price Target
$43.00
Low Stock Price Target
$25.00
Potential Upside/Downside
+36.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.93
Research Coverage
14 Analysts

Profitability

Net Income
$-176,150,000.00
Pretax Margin
-42.35%

Debt

Sales & Book Value

Annual Sales
$280.91 million
Book Value
$5.46 per share

Miscellaneous

Free Float
52,408,000
Market Cap
$1.38 billion
Optionable
Optionable
Beta
0.95
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report














PHR Stock Analysis - Frequently Asked Questions

Should I buy or sell Phreesia stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Phreesia in the last twelve months. There are currently 1 hold rating and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" PHR shares.
View PHR analyst ratings
or view top-rated stocks.

What is Phreesia's stock price target for 2024?

14 Wall Street analysts have issued 1 year price targets for Phreesia's stock. Their PHR share price targets range from $25.00 to $43.00. On average, they anticipate the company's share price to reach $33.79 in the next twelve months. This suggests a possible upside of 36.5% from the stock's current price.
View analysts price targets for PHR
or view top-rated stocks among Wall Street analysts.

How have PHR shares performed in 2024?

Phreesia's stock was trading at $23.15 on January 1st, 2024. Since then, PHR shares have increased by 7.0% and is now trading at $24.76.
View the best growth stocks for 2024 here
.

Are investors shorting Phreesia?

Phreesia saw a increase in short interest in January. As of January 31st, there was short interest totaling 2,150,000 shares, an increase of 20.8% from the January 15th total of 1,780,000 shares. Based on an average daily volume of 643,000 shares, the short-interest ratio is currently 3.3 days.
View Phreesia's Short Interest
.

When is Phreesia's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024.
View our PHR earnings forecast
.

How can I listen to Phreesia's earnings call?

Phreesia will be holding an earnings conference call on Thursday, March 14th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Phreesia's earnings last quarter?

Phreesia, Inc. (NYSE:PHR) issued its earnings results on Wednesday, December, 6th. The company reported ($0.58) EPS for the quarter, topping the consensus estimate of ($0.68) by $0.10. The company had revenue of $91.62 million for the quarter, compared to analyst estimates of $89.60 million. Phreesia had a negative trailing twelve-month return on equity of 54.28% and a negative net margin of 42.70%. Phreesia's revenue was up 25.3% on a year-over-year basis. During the same period last year, the business earned ($0.76) earnings per share.

What ETFs hold Phreesia's stock?
What guidance has Phreesia issued on next quarter's earnings?

Phreesia updated its FY 2025 earnings guidance on Monday, December, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $424.0 million-$434.0 million, compared to the consensus revenue estimate of $449.1 million.

What is Chaim Indig's approval rating as Phreesia's CEO?

172 employees have rated Phreesia Chief Executive Officer Chaim Indig on Glassdoor.com. Chaim Indig has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Phreesia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phreesia investors own include Fastly (FSLY), Zscaler (ZS), Okta (OKTA), DocuSign (DOCU), HealthEquity (HQY), Block (SQ), Appian (APPN), Walt Disney (DIS), Globant (GLOB) and Invitae (NVTA).

When did Phreesia IPO?

(PHR) raised $127 million in an initial public offering (IPO) on Thursday, July 18th 2019. The company issued 7,800,000 shares at $15.00-$17.62 per share. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as the underwriters for the IPO.

Who are Phreesia's major shareholders?

Phreesia's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.32%), Brown Advisory Inc. (7.10%), Franklin Resources Inc. (2.67%), GW&K Investment Management LLC (2.17%), Ophir Asset Management Pty Ltd (1.98%) and Granahan Investment Management LLC (1.91%). Insiders that own company stock include Allison C Hoffman, Allison C Hoffman, Amy Beth Vanduyn, Balaji Gandhi, Chaim Indig, David Linetsky, Edward L Cahill, Evan Roberts, Gillian Munson, Janet Gunzburg, Mark Douglas Smith, Michael J Davidoff, Michael Weintraub and Randy Rasmussen.
View institutional ownership trends
.

How do I buy shares of Phreesia?

Shares of PHR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:PHR) was last updated on 3/1/2024 by MarketBeat.com Staff